NO2670412T3 - - Google Patents

Info

Publication number
NO2670412T3
NO2670412T3 NO12741560A NO12741560A NO2670412T3 NO 2670412 T3 NO2670412 T3 NO 2670412T3 NO 12741560 A NO12741560 A NO 12741560A NO 12741560 A NO12741560 A NO 12741560A NO 2670412 T3 NO2670412 T3 NO 2670412T3
Authority
NO
Norway
Application number
NO12741560A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011900325A external-priority patent/AU2011900325A0/en
Application filed filed Critical
Publication of NO2670412T3 publication Critical patent/NO2670412T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO12741560A 2011-02-02 2012-02-02 NO2670412T3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2011900325A AU2011900325A0 (en) 2011-02-02 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
PCT/AU2012/000091 WO2012103588A1 (en) 2011-02-02 2012-02-02 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides

Publications (1)

Publication Number Publication Date
NO2670412T3 true NO2670412T3 (no) 2018-06-02

Family

ID=46602012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12741560A NO2670412T3 (no) 2011-02-02 2012-02-02

Country Status (15)

Country Link
US (6) US9101650B2 (no)
EP (1) EP2670412B1 (no)
JP (1) JP5883458B2 (no)
KR (1) KR101840079B1 (no)
CN (1) CN103415293B (no)
AU (1) AU2012212398B2 (no)
CA (1) CA2826166C (no)
DK (1) DK2670412T3 (no)
ES (1) ES2664611T3 (no)
MY (1) MY164728A (no)
NO (1) NO2670412T3 (no)
PT (1) PT2670412T (no)
SG (1) SG192238A1 (no)
TW (1) TWI520740B (no)
WO (1) WO2012103588A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6444399B2 (ja) * 2013-10-22 2018-12-26 セル レセプター アーゲー 癌の処置に用いるための硫酸化多糖
SG11202000938YA (en) * 2017-08-04 2020-02-27 Paradigm Biopharmaceuticals Ltd Treatment of bone marrow pathologies with polysulfated polysaccharides
WO2019157560A1 (en) 2018-02-16 2019-08-22 Proteobioactives Pty Limited Methods and compositions for the treatment of pain and/or inflammation
WO2019165498A1 (en) * 2018-02-28 2019-09-06 Paradigm Biopharmaceuticals Ltd Treatment of post-operative joint pain with polysulfated polysaccharides
JP2022512662A (ja) 2018-10-10 2022-02-07 パラダイム バイオファーマシューティカルズ リミテッド ポリ硫酸化多糖を用いた疼痛の治療

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668116A (en) 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US6593310B1 (en) 2000-11-21 2003-07-15 Arthropharm Pty. Ltd. Treatment of osteoporosis
US6564083B2 (en) * 2000-12-18 2003-05-13 Hoffmann-La Roche Inc. Bone marrow edema as predictive of susceptibility to developing progressive osteoarthritis
DE10225551A1 (de) * 2002-06-06 2003-12-24 Schering Ag Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind
KR101923152B1 (ko) * 2007-12-04 2018-11-28 프로테오바이오엑티브스 피티와이 엘티디 전구 세포의 보호 및 그의 분화 조절

Also Published As

Publication number Publication date
US20140024614A1 (en) 2014-01-23
US20240156858A1 (en) 2024-05-16
US9861657B2 (en) 2018-01-09
KR20140012655A (ko) 2014-02-03
US20180021369A1 (en) 2018-01-25
PT2670412T (pt) 2018-03-20
ES2664611T3 (es) 2018-04-20
TWI520740B (zh) 2016-02-11
MY164728A (en) 2018-01-30
AU2012212398A1 (en) 2013-09-19
EP2670412A4 (en) 2015-07-08
CA2826166A1 (en) 2012-08-09
US20210015849A1 (en) 2021-01-21
US20220362284A1 (en) 2022-11-17
US9101650B2 (en) 2015-08-11
US11406660B2 (en) 2022-08-09
EP2670412B1 (en) 2018-01-03
AU2012212398B2 (en) 2014-06-05
JP2014504613A (ja) 2014-02-24
US20150297633A1 (en) 2015-10-22
EP2670412A1 (en) 2013-12-11
CA2826166C (en) 2017-05-09
US10610542B2 (en) 2020-04-07
KR101840079B1 (ko) 2018-03-19
SG192238A1 (en) 2013-09-30
DK2670412T3 (en) 2018-03-12
WO2012103588A1 (en) 2012-08-09
TW201309307A (zh) 2013-03-01
CN103415293B (zh) 2016-08-10
CN103415293A (zh) 2013-11-27
JP5883458B2 (ja) 2016-03-15

Similar Documents

Publication Publication Date Title
BR112013031251A2 (no)
BR112013027245A2 (no)
BR112013026905A2 (no)
BR112013022995A2 (no)
BR112013027830A2 (no)
BR112013028733A2 (no)
BR112013027121A2 (no)
AP2016009466A0 (no)
BR112013031556A2 (no)
BR112013032380A2 (no)
BR112013032377A2 (no)
BR112013032368A2 (no)
BR112013018949A2 (no)
BR112013026895A2 (no)
BR112013027761A2 (no)
BR112013027836A2 (no)
BR112013032392A2 (no)
BR112013027871A2 (no)
BR112013032394A2 (no)
BR112013030734A2 (no)
BR112013027657A2 (no)
BR112013027112A2 (no)
BR112013027874A2 (no)
BR112013027764A2 (no)
CN301578350S (zh) 茶几(rncj-7)